Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara J Newmann

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
AIDS (London, England)|October 4, 2013
Cost, cost-efficiency and cost-effectiveness of integrated family planning and HIV servicesStarley B Shade, Sebastian Kevany, Maricianah Onono, et al.
The Lancet. HIV|November 2, 2015
Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort studyRena C Patel, Maricianah Onono, Monica Gandhi, et al.
The Lancet. Microbe|June 6, 2022
Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trialEric Armstrong, Anke Hemmerling, Steve Miller, et al.
The Journal of Clinical Investigation|February 3, 2022
Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilliEric Armstrong, Anke Hemmerling, Steve Miller, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
AIDS (London, England)|October 4, 2013
Cost, cost-efficiency and cost-effectiveness of integrated family planning and HIV servicesStarley B Shade, Sebastian Kevany, Maricianah Onono, et al.
The Lancet. HIV|November 2, 2015
Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort studyRena C Patel, Maricianah Onono, Monica Gandhi, et al.
The Lancet. Microbe|June 6, 2022
Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trialEric Armstrong, Anke Hemmerling, Steve Miller, et al.
The Journal of Clinical Investigation|February 3, 2022
Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilliEric Armstrong, Anke Hemmerling, Steve Miller, et al.
Pageof 4